Steffin DHM, Muhsen IN, Hill LC, et al. Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs. Blood. 2022;140(1):16-24.

In “Acknowledgments” on pages 22-23, support provided by the National Gene Vector Biorepository at Indiana University under National Heart, Lung, and Blood Institute contract 75N92019D00018 should have been cited.